GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
19.84
-0.65 (-3.17%)
Sep 9, 2025, 2:39 PM EDT
GSK plc Market Cap
GSK plc has a market cap or net worth of $80.70 billion as of September 9, 2025. Its market cap has decreased by -9.26% in one year.
Market Cap
80.70B
Enterprise Value
98.69B
Revenue
43.34B
Ranking
n/a
PE Ratio
17.21
Stock Price
$19.84
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has decreased from 96.45B to 80.70B, a decrease of -16.33%. That is a compound annual growth rate of -0.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 80.70B | 17.32% |
| Dec 31, 2024 | 68.79B | -8.64% |
| Dec 29, 2023 | 75.29B | 7.04% |
| Dec 30, 2022 | 70.34B | -35.43% |
| Dec 31, 2021 | 108.95B | 19.45% |
| Dec 31, 2020 | 91.20B | -21.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |